Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

The Performance of Patient Support Program in Early Stage Breast Cancer (ARI NIS)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
AstraZeneca
ClinicalTrials.gov Identifier:
NCT00769080
First received: October 6, 2008
Last updated: November 28, 2011
Last verified: November 2011